← The SEC Ephemeris: the whole map
AbbVie Inc. AGN-151586
In the graph: all 7 documents (154 pages).
- Application
- BLA 761459
- Ticker
- ABBV
- Product
- AGN-151586
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- April 22, 2026 · June 18, 2024 · March 17, 2023
From FDA letters and SEC filings. Not investment or medical advice.